You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

CLORAZEPATE DIPOTASSIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Clorazepate Dipotassium patents expire, and when can generic versions of Clorazepate Dipotassium launch?

Clorazepate Dipotassium is a drug marketed by Able, Am Therap, Dash Pharms, Dava Pharms Inc, Gd Searle Llc, Purepac Pharm, Quantum Pharmics, Rising, Usl Pharma, Warner Chilcott, Watson Labs, Aurobindo Pharma, Aurolife Pharma Llc, Corepharma, Lederle, Novitium Pharma, Sun Pharm Inds Ltd, and Taro. and is included in fifty-eight NDAs.

The generic ingredient in CLORAZEPATE DIPOTASSIUM is clorazepate dipotassium. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the clorazepate dipotassium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Clorazepate Dipotassium

A generic version of CLORAZEPATE DIPOTASSIUM was approved as clorazepate dipotassium by AUROBINDO PHARMA on July 17th, 1987.

  Try a Trial

Drug patent expirations by year for CLORAZEPATE DIPOTASSIUM
Drug Prices for CLORAZEPATE DIPOTASSIUM

See drug prices for CLORAZEPATE DIPOTASSIUM

Recent Clinical Trials for CLORAZEPATE DIPOTASSIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assistance Publique - Hôpitaux de ParisPhase 3
Ranbaxy Laboratories LimitedN/A

See all CLORAZEPATE DIPOTASSIUM clinical trials

Pharmacology for CLORAZEPATE DIPOTASSIUM
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for CLORAZEPATE DIPOTASSIUM

US Patents and Regulatory Information for CLORAZEPATE DIPOTASSIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs CLORAZEPATE DIPOTASSIUM clorazepate dipotassium TABLET;ORAL 071854-001 Feb 9, 1988 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Aurobindo Pharma CLORAZEPATE DIPOTASSIUM clorazepate dipotassium TABLET;ORAL 071858-003 Jul 17, 1987 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Labs CLORAZEPATE DIPOTASSIUM clorazepate dipotassium CAPSULE;ORAL 071879-001 Mar 15, 1988 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.